Bart Westerman

DRS.

19972019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

  • 16 Article
  • 3 Review article
  • 1 Research VU University Amsterdam, graduation VU University Amsterdam

The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation

Saleem, H., Kulsoom Abdul, U., Küçükosmanoglu, A., Houweling, M., Cornelissen, F. M. G., Heiland, D. H., Hegi, M. E., Kouwenhoven, M. C. M., Bailey, D., Würdinger, T. & Westerman, B. A., Mar 2019, In : Drug Resistance Updates. 43, p. 29-37 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

EORTC PAMM Group, Jul 2019, In : Anticancer Research. 39, 7, p. 3303-3309 7 p.

Research output: Contribution to journalReview articleAcademicpeer-review

GBM Drug Bank-a new resource for glioblastoma drug discovery and informatics research

Svensson, F., Westerman, B., Würdinger, T. & Bailey, D., 2018, In : Neuro-Oncology. 20, 12, p. 1680-1681

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8

Berenguer, J., Lagerweij, T., Zhao, X. W., Dusoswa, S., van der Stoop, P., Westerman, B., de Gooijer, M. C., Zoetemelk, M., Zomer, A., Crommentuijn, M. H. W., Wedekind, L. E., López-López, À., Giovanazzi, A., Bruch-Oms, M., Meulen-Muileman, I. H. V. D., Reijmers, R. M., van Kuppevelt, T. H., García-Vallejo, J. J., van Kooyk, Y., Tannous, B. A. & 9 othersWesseling, P., Koppers-Lalic, D., Vandertop, W. P., Noske, D. P., van Beusechem, V. W., van Rheenen, J., Pegtel, D. M., van Tellingen, O. & Wurdinger, T., 13 Mar 2018, In : Journal of Extracellular Vesicles. 7, 1, 1446660.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma

Narayan, R. S., Gasol, A., Slangen, P. L. G., Cornelissen, F. M. G., Lagerweij, T., Veldman, H. Y. Y. E., Dik, R., van den Berg, J., Slotman, B. J., Würdinger, T., Haas-Kogan, D. A., Stalpers, L. J. A., Baumert, B. G., Westerman, B. A., Theys, J. & Sminia, P., Feb 2018, In : Molecular Cancer Therapeutics. 17, 2, p. 347-354 8 p.

Research output: Contribution to journalArticleAcademicpeer-review